Why Private Equity Is Investing in India’s Hospitals
For a family arranging surgery, the immediate questions are practical: who will perform it, how far away is the hospital and how much will the treatment cost?

For a family arranging surgery, the immediate questions are practical: who will perform it, how far away is the hospital and how much will the treatment cost? For a hospital owner, providing that care means recruiting clinicians, maintaining equipment and paying staff long before every bill is collected.
Private equity can supply money for those commitments and for expansion. Investors, in turn, expect the hospital business to become more valuable over time.
Recent investments in India show several ways that can happen, from funding a growing hospital chain to acquiring an established network. The investment case deserves a closer look than the number of beds announced. A hospital needs patients, capable staff, dependable collections and enough financial room to maintain standards while it grows.
What do recent investments show?
On 17 September 2026, Advent International announced an agreement to invest ₹3,150 crore of new capital in Yatharth Hospitals. Under the announced terms, Advent would hold 24.9% upon completion, subject to closing conditions, while the Tyagi family would remain the largest shareholder.
This is a proposed minority investment in a listed company. It illustrates how a private-equity investor can help finance expansion without buying the whole business.
In August, KKR announced an agreement to acquire Medicover’s Indian hospital operations. The network was described at announcement as having 24 hospitals and about 4,800 beds across southern and western India.
These transactions involve different ownership arrangements and regional footprints. They should be assessed on their own terms.
The useful questions are what the investor is buying, who receives the money and how the hospital business is expected to improve. A prominent investor’s involvement is a reason to examine the transaction, rather than a substitute for doing so.
Why does specialist care attract capital?
The commercial case rests partly on the investment required to provide complex care. A hospital offering specialist services needs suitable facilities, equipment, trained teams and reliable support around the clock.
That creates a possible role for an investor who can fund expansion over several years. An established operator may already have clinical leadership and a reputation, but need capital to open another site or add a service.
There is also a case for bringing several hospitals into a network. Shared purchasing, financial systems and administrative support may reduce duplication. Clinical collaboration can help smaller facilities access expertise elsewhere in the group.
These are potential benefits. A larger network can also become harder to manage, especially if it expands faster than its staffing and operating systems can support.
Our assessment is that the strongest investment case would connect each expansion project to a specific local need and a credible delivery plan. A broad statement about India’s healthcare demand cannot establish whether a particular hospital will attract enough patients.
Where does the investment money go?
The distinction between new capital and a sale of existing shares matters.
In a primary investment, a company issues securities to raise money. That capital can support the business, subject to the agreed terms and its spending plans. Advent describes the Yatharth proposal as primary capital.
In a secondary transaction, an investor buys existing shares from their owners. The sellers receive the purchase money. The hospital may benefit from a new owner’s expertise or subsequent funding, but the share purchase itself does not necessarily put cash into its accounts.
Some transactions combine both approaches.
Investors should trace the proposed funding to its intended uses: new facilities, equipment, acquisitions, debt repayment or working capital. They should also ask when the money becomes available and whether further funding will be needed.
A large transaction value can sound like a large expansion budget. The two should only be equated when the documents support that conclusion.
How many beds can actually serve patients?
A bed count needs a definition.
Capacity planned for a future building differs from installed capacity. Installed beds may still need equipment, approvals or staff before they can be used. Even operational beds will not all be occupied every day.
Before comparing hospital groups, check whether their reported figures use the same basis. A group with newly opened facilities may have a different occupancy profile from one made up mainly of established hospitals.
Occupancy measures the use of available capacity, but the denominator matters. Opening a new wing can lower the reported percentage even if the number of patients treated rises.
Investors should ask for results from established hospitals separately from new sites. That helps reveal whether existing operations are improving and how much the expansion is costing.
Beds also need supporting capacity. More inpatient rooms will achieve little if operating theatres, diagnostic services or nursing teams cannot accommodate the additional workload.
Who pays the bill, and can they afford it?
A hospital can receive payments from patients, private insurers, employers and public programmes. Each source needs separate attention because prices, eligibility, documentation and payment arrangements can differ.
India’s National Health Accounts estimates for 2022–23, released in May 2026, put household out-of-pocket spending at 43.4% of total health expenditure. That is a historical national measure, not a current percentage for any particular hospital.
It nevertheless provides useful context for assessing affordability. A forecast that assumes patients can absorb repeated price increases needs evidence.
For an individual hospital, investors should examine the share of revenue from each payer, agreed tariffs, rejected or disputed claims and the time taken to collect payment.
An increase in average revenue per patient also needs explanation. It might reflect more complex treatment or a change in the services provided. It should not automatically be interpreted as a price increase.
A sound assessment asks whether the hospital can provide appropriate care at prices its patients and payers can sustain.
Are higher earnings becoming cash?
Hospital accounts can show revenue before the money has been collected. Expansion also requires spending that may not appear as an immediate operating expense.
That makes cash flow essential to the assessment.
EBITDA, or earnings before interest, tax, depreciation and amortisation, can help compare operating performance. It leaves out several demands on cash, including equipment purchases, loan repayments and money tied up in unpaid bills.
Investors should compare operating cash flow with reported earnings and examine how receivables change over time. If unpaid bills rise faster than revenue, the reasons deserve attention.
Capital expenditure needs separating too. Replacing essential equipment is different from building a new hospital, although both require funding.
A useful review would also separate the costs of new sites from established operations. An adjusted profit measure that removes expansion losses may help explain the mature business, but those losses still have to be financed.
The question is whether the group can fund its commitments through a realistic period of growth, including delays.
What should investors check about clinical quality and staffing?
The quality review should be as thorough as the financial review.
Accreditation can be one starting point. India’s National Accreditation Board for Hospitals and Healthcare Providers assesses hospitals against quality and patient-safety standards. Investors should verify the status and scope of accreditation at each relevant facility.
They should also ask what happens in daily practice: how incidents are reported, how complaints are handled, whether staffing matches the services offered and who can challenge a commercial decision on clinical grounds.
Outcome measures need context. A hospital treating more complex cases may have different results from one handling less severe conditions. Comparisons should account for those differences.
Staffing deserves particular attention when expansion depends on a small number of specialist doctors. Investors should examine retention, recruitment plans, clinical leadership and the terms on which key clinicians work.
Procurement savings and better administration may support a hospital. Reducing essential staffing or maintenance to meet a short-term earnings target would be a different proposition. The investment plan should make clear how financial decisions are reviewed for their effect on care.
Does the price leave room for a reasonable return?
An attractive business can still be a poor investment at an excessive price.
Investors should check whether the valuation uses current earnings or forecasts for hospitals that have yet to reach steady operations. They should understand the assumed opening dates, occupancy, treatment mix, costs and additional capital required.
A price-per-bed comparison is only a starting point. It can conceal differences in land ownership, leases, equipment, clinical services and the maturity of individual hospitals.
Ownership rights matter alongside price. A negotiated institutional investment may include board representation or other protections that an ordinary shareholder does not receive.
For a private-equity fund, the eventual sale of its stake is another consideration. Possible routes include a sale to another investor or an industry buyer, or a public-market exit where appropriate. The expected timing and valuation remain uncertain.
The model should still make sense if expansion takes longer or a future buyer pays a lower earnings multiple. Assuming that the next owner will pay more is a weak foundation for an investment.
What should investors check before committing?
A hospital investment deserves clear answers to these questions:
- Is the transaction new funding, a purchase from existing owners or a mixture of both?
- What ownership rights does the investor receive, and what conditions remain before completion?
- How much capacity is operational, staffed and available for use?
- How do established hospitals perform separately from new facilities?
- Who pays for treatment, and how quickly are bills collected?
- What spending is needed to maintain quality and complete expansion?
- Can the business meet its financing obligations if growth falls short?
- How are clinical outcomes, staffing and patient complaints monitored?
Private equity can help a hospital group fund facilities, strengthen administration and expand services. Whether that produces a durable business depends on how the money is used and how the hospitals are run.
The investor’s task is to follow the connection between capital, care and cash flow. New capacity needs capable staff. Patients need appropriate treatment at a manageable cost. The business needs to collect enough money to maintain those services and meet its obligations.
The most useful evidence will come from that operating record over time. A deal announcement marks the investment decision; it cannot settle whether the investment will succeed.
Keep reading
Recommended Articles to read
Based on this article and the topics you have read in this browser.


